Idrabiotaparinux sodium

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIdrabiotaparinux sodium
Drug Alias Nameidrabiotaparinux sodique艾比肝素钠idrabiotaparinuxum natricum噻咪艾屈肝素钠SSR-126517 +[7] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsVenous ThrombosisThrombosisEmbolism +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[51] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Aventis-Boulevard IndustrielSanofi-Aventis Recherche & Developpement Le TraitSanofi +[6] 
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisThrombosisEmbolism +[5] 

Other Information

ATC CodeN/A
Related LinksWikipedia